Heat shock protein-based vaccines and immunotherapies
US7618637B2 · kind B2 · utility
0Cited by
26References
48Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2002 |
| Grant date | Nov 17, 2009 |
| Priority date | — |
| Expiry date | May 25, 2023 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/828
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods and compositions for inducing an immune response in a subject, wherein the subject is administered an effective amount of at least one heat shock protein in combination with one or more defined target antigens. These methods and compositions may be used in the treatment of infectious eases and cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.